CHF 1535 200/6µg

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF 1535 200/6µg, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients [Phase 3]